- Home
- HGTY vs INVA Comparison
HGTY vs INVA Comparison
Compare HGTY & INVA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HGTY
- INVA
- Stock Information
- Founded
- HGTY 1984
- INVA 1996
- Country
- HGTY United States
- INVA United States
- Employees
- HGTY N/A
- INVA N/A
- Industry
- HGTY Specialty Insurers
- INVA Biotechnology: Pharmaceutical Preparations
- Sector
- HGTY Finance
- INVA Health Care
- Exchange
- HGTY Nasdaq
- INVA Nasdaq
- Market Cap
- HGTY 1.1B
- INVA 1.3B
- IPO Year
- HGTY N/A
- INVA 2004
- Fundamental
- Price
- HGTY $11.77
- INVA $20.48
- Analyst Decision
- HGTY Hold
- INVA Strong Buy
- Analyst Count
- HGTY 3
- INVA 4
- Target Price
- HGTY $12.00
- INVA $40.25
- AVG Volume (30 Days)
- HGTY 298.0K
- INVA 760.2K
- Earning Date
- HGTY 08-04-2025
- INVA 11-05-2025
- Dividend Yield
- HGTY N/A
- INVA N/A
- EPS Growth
- HGTY 90.09
- INVA N/A
- EPS
- HGTY 0.20
- INVA 0.53
- Revenue
- HGTY $1,303,397,000.00
- INVA $370,229,000.00
- Revenue This Year
- HGTY $15.41
- INVA $8.17
- Revenue Next Year
- HGTY $15.88
- INVA $12.06
- P/E Ratio
- HGTY $57.92
- INVA $39.25
- Revenue Growth
- HGTY 17.90
- INVA 12.02
- 52 Week Low
- HGTY $8.03
- INVA $16.67
- 52 Week High
- HGTY $12.11
- INVA $22.00
- Technical
- Relative Strength Index (RSI)
- HGTY 62.16
- INVA 56.42
- Support Level
- HGTY $10.97
- INVA $19.60
- Resistance Level
- HGTY $11.76
- INVA $21.11
- Average True Range (ATR)
- HGTY 0.36
- INVA 0.51
- MACD
- HGTY 0.05
- INVA 0.05
- Stochastic Oscillator
- HGTY 94.63
- INVA 57.89
About HGTY Hagerty Inc.
Hagerty Inc is a provider of specialty automotive insurance. The company underwrites, sells, and services classic car and enthusiast vehicle insurance policies. Substantial revenue is derived from Commission and fees. Geographically it serves Europe, Canada, and the United States.
About INVA Innoviva Inc.
Innoviva Inc is a company with a portfolio of royalties healthcare assets. It has three primary sets of assets: a royalty portfolio, operating assets in critical care and infectious disease, and other strategic healthcare assets. Its product offering includes Relvar/Breo/Ellipta, Anoro, Ellipta, Trelegy, Ellipta and others.